Endeavor BioMedicines

Endeavor BioMedicines is a clinical-stage biotechnology company based in San Diego, California, developing transformational medicines for life-threatening diseases. The company's lead investigational candidates include an inhibitor of the Hedgehog signaling pathway for fibrotic lung disease and a human epidermal growth factor 3-targeted antibody-drug conjugate for the treatment of solid tumors.